Skip to content

Comparing the pain relief effect of oral 10 percent glucose and expressed breast milk during venous blood sampling among hyperbilirubinemic neonates

Comparing the pain relief effect of oral 10 percent glucose and expressed breast milk during venous blood sampling among hyperbilirubinemic neonates

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201109147557N1
Enrollment
35
Registered
2013-10-29
Start date
2012-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperbilirubinemia. Neonatal jaundice from other specified causes

Interventions

Intervention 1: expressed breast milk: one ml expressed breast milk once, two minutes before blood sampling. Intervention 2: glucose 10 percent: one ml glucose 10 percent once, two minutes before bl
Prevention
expressed breast milk: one ml expressed breast milk once, two minutes before blood sampling.
glucose 10 percent: one ml glucose 10 percent once, two minutes before blood sampling.

Sponsors

Vice chancellor for research, Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 1 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Full- term neonates (gestational age 37 to 42 weeks) who needed Venipuncture in order to control the neonatal bilirubin 2. No cotraindication for oral feeding. 3. Tranquilizers and painkillers had not been received at least 3 hours before blood sampling 4. The baby was awake before blood sampling 5. The mother had not received any drugs 6. The infant has not any anomalies, cleft lip and palate. 7. Mother was not diabetic. 8.Infants were fed breast milk of his/her own mother. 9. Clinical signs indicating an increase in bilirubin (according to physician diagnosis). Exclusion criteria for study: 1. neonate discharge before second blood sampling 2.oral feeding contraindication or treatment change during follow up due to an unexpected situation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: 2 minutes before blood sampling, intervention during 5 minutes, 3 minutes after intervention. Method of measurement: Pain scale measurement NIPS(Neonatale Infant Pain Scale).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Noroozi Behjat

Kerman University of Medical Sciences

Majidnoroozi88@yahoo.com+98 34 1226 3787

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026